Clémence Martin

发表

Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries

P. Burgel, Clémence Martin, 2021, European Respiratory Journal.

Cystic Fibrosis in 2021: "The Times They Are A-Changin".

P. Burgel, Clémence Martin, L. Regard, 2021, Archivos de bronconeumologia.

Acute and chronic non-pulmonary complications in adults with cystic fibrosis

P. Burgel, G. Chassagnon, Clémence Martin, 2018, Expert review of respiratory medicine.

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

P. Burgel, A. Munck, C. Hamard, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Effective control of Staphylococcus aureus lung infection despite tertiary lymphoid structure disorganisation

P. Burgel, J. Teillaud, S. Sibéril, 2020, European Respiratory Journal.

Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.

P. Burgel, G. Thévenot, M. Cassatella, 2016, American journal of respiratory cell and molecular biology.

Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.

P. Burgel, E. Audureau, N. Veziris, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.

J. Benoît, C. Picard, C. Goulvestre, 2012, Journal of medical microbiology.

Mediastinal Tuberculosis in an Adult Patient with Cystic Fibrosis

P. Burgel, C. Poyart, D. Dusser, 2010, Journal of Clinical Microbiology.

An automated computed tomography score for the cystic fibrosis lung

N. Paragios, M. Revel, E. Zacharaki, 2018, European Radiology.

Prognostic value of six minute walk test in cystic fibrosis adults.

P. Burgel, J. Paillasseur, I. Fajac, 2013, Respiratory medicine.

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

P. Burgel, A. Paugam, D. Hubert, 2016, Infection and drug resistance.

Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021.

P. Devillier, C. Morélot-Panzini, N. Roche, 2022, Respiratory medicine and research.

Should bronchoscopy be advocated to study airway remodelling and inflammation in adults with cystic fibrosis?

P. Burgel, I. Fajac, D. Dusser, 2011, Thorax.

Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?

P. Burgel, Clémence Martin, 2020, European Respiratory Journal.

Lung immunoglobulin A immunity dysregulation in cystic fibrosis

S. Verleden, P. Burgel, C. Bouzin, 2020, EBioMedicine.

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?

P. Burgel, Clémence Martin, L. Regard, 2018, European Respiratory Journal.

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.

S. Leroy, P. Burgel, J. Paillasseur, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France

P. Burgel, Clémence Martin, L. Regard, 2022, Cells.

"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective.

P. Burgel, I. Sermet-Gaudelus, J. Bend, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis.

Karen L. Robinson, C. Castellani, K. Raraigh, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients With Cystic Fibrosis.

P. Burgel, N. Dupin, C. Lheure, 2022, JAMA dermatology.

Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.

J. Chiche, J. Mira, D. Grimaldi, 2012, The Journal of infectious diseases.

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity

D. Leduc, L. Touqui, P. Burgel, 2014, Nature Communications.

Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations

P. Burgel, F. Pène, V. Witko-Sarsat, 2022, Frontiers in Immunology.

CFTR Modulators: Current Status and Evolving Knowledge

P. Burgel, Clémence Martin, L. Regard, 2022, Seminars in Respiratory and Critical Care Medicine.

Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19

P. Burgel, Edroaldo L. Rocha, Matthew S Macauley, 2022, British journal of pharmacology.

Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis

L. Touqui, P. Burgel, M. Alifano, 2017, European Respiratory Journal.

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.

P. Burgel, J. Paillasseur, I. Durieu, 2021, American journal of respiratory and critical care medicine.

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France

P. Burgel, F. Kerbaul, R. Dorent, 2021, American journal of respiratory and critical care medicine.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant

P. Burgel, I. Durieu, I. Sermet-Gaudelus, 2023, European Respiratory Journal.

Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis

P. Burgel, V. Witko-Sarsat, I. Honoré, 2022, European Respiratory Journal.

CFTR Modulators: Current Status and Evolving Knowledge

P. Burgel, Clémence Martin, L. Regard, 2022, Seminars in Respiratory and Critical Care Medicine.

Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor–ivacaftor in people with cystic fibrosis

M. Revel, P. Reix, P. Burgel, 2021, European Respiratory Journal.

Change in Lung Function after Initiation of Elexacaftor–Tezacaftor–Ivacaftor: Do Not Forget Anatomy!

P. Burgel, G. Chassagnon, Clémence Martin, 2022, American journal of respiratory and critical care medicine.

The changing epidemiology of cystic fibrosis: the implications for adult care.

P. Burgel, Clémence Martin, L. Regard, 2022, Chest.

Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD?

P. Burgel, J. Frija-Masson, Clémence Martin, 2014, Drugs.

Bronchodilator Response Assessment of the Small Airways Obstructive Pattern

C. Delclaux, P. Bokov, M. Essalhi, 2017, The open respiratory medicine journal.

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review

N. Roche, P. Burgel, Clémence Martin, 2021, International journal of chronic obstructive pulmonary disease.

COPD_A_226688 2363..2373

N. Roche, P. Burgel, Clémence Martin, 2021 .

Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension

M. Humbert, C. Péchoux, P. Burgel, 2021, European Respiratory Journal.

CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium

L. Touqui, P. Burgel, G. Thévenot, 2013, European Respiratory Journal.

Increased IgA Expression in Lung Lymphoid Follicles in Severe COPD

B. Weynand, P. Burgel, G. Gayan‐Ramirez, 2018 .

Host–microbe interactions in distal airways: relevance to chronic airway diseases

L. Touqui, J. Dalphin, P. Burgel, 2015, European Respiratory Review.

Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

N. Paragios, M. Revel, E. Zacharaki, 2020, Radiology. Cardiothoracic imaging.

Dysfunctional lung anatomy and small airways degeneration in COPD

P. Burgel, J. Frija, Clémence Martin, 2013, International journal of chronic obstructive pulmonary disease.

Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected Lungs.

P. Burgel, J. Teillaud, S. Sibéril, 2018, Methods in molecular biology.

Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.

P. Burgel, B. Leynaert, M. Benallaoua, 2008, The American journal of pathology.

CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes

P. Burgel, E. Larger, H. Mosnier-Pudar, 2023, Scientific reports.

Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease

B. Weynand, P. Burgel, G. Gayan‐Ramirez, 2019, American journal of respiratory and critical care medicine.

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

P. Burgel, A. Paugam, D. Hubert, 2016 .

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

P. Burgel, A. Paugam, D. Hubert, 2016, Infection and Drug Resistance.

Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report

V. Tsatsaris, S. Chhun, J. Treluyer, 2020, Allergy, asthma & immunology research.

Critical role of cytosolic phospholipase A2&agr; in bronchial mucus hypersecretion in CFTR-deficient mice

L. Touqui, P. Burgel, M. Chignard, 2010, European Respiratory Journal.

CRITICAL ROLE OF CYTOSOLIC PHOSPHOLIPASE A2α IN BRONCHIAL MUCUS HYPER-SECRETION IN CFTR-DEFICIENT MICE

L. Touqui, M. Chignard, B. Scholte, 2010 .

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

C. Goss, H. Rodgers, P. Burgel, 2022, Journal of Cystic Fibrosis.

Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo

P. Burgel, G. Thévenot, I. Fajac, 2011, European Respiratory Journal.

Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues.

M. Wilschanski, J. Bouchara, S. van Koningsbruggen-Rietschel, 2024, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.